Title : Antagonism of thromboxane receptors by diclofenac and lumiracoxib.

Pub. Date : 2007 Dec

PMID : 17965743






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS AND IMPLICATIONS: Diclofenac and lumiracoxib, in addition to being COX unselective and highly COX-2 selective inhibitors, respectively, displayed a previously unknown pharmacological activity, namely TP receptor antagonism. Diclofenac mitochondrially encoded cytochrome c oxidase II Homo sapiens